Rajiv de Silva, President & COO, Specialty Pharma at Valeant Pharmaceuticals International, Inc. (VRX), sold 220,694 shares at $54.78 ($12.0M) on 2012-11-06, disclosed to the SEC on 2012-11-08.
Open-market sale of $12.0M VRX by President & COO, Specialty Pharma. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.05 | 121,054 | $6.5M | 54.5% |
| 2 | $54.78 | 99,640 | $5.5M | 45.5% |
| Total | $54.38 avg | 220,694 | $12.0M | 100% |
| Filing → |
| ENDP | BUY | 2015-11-12 | $500K | — | Filing → |
| VRX | SELL | 2012-11-09 | $4.1M | — | Filing → |
| VRX | BUY | 2011-08-16 | $250K | — | Filing → |